Skip to Main Navigation
Skip to Page Content
COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/13758

Target Organs and Levels of Evidence for TR-341

Toxicology and Carcinogenesis Studies of Nitrofurantoin (CASRN 67-20-9) in F344/N Rats and B6C3F1 Mice (Feed Studies)

Chemical (Study Title)
CASRN		 Peer Review Date Route/Exposure Levels Study Laboratory
Nitrofurantoin
67-20-9		 04/18/1988 Dosed-Feed
FR: 0,600,1300, MR&M: 0,1300,2500 PPM/50 PER GROUP		 Southern Research Institute

Levels of Evidence

Male Rats: Some Evidence
Type Organ/Tissue (Lesion)
Neoplastic Lesions
  • Kidney Tubular Cell: ADENOMA 0/50 1/50 2/50 OR CARCINOMA 0/50 0/50 1/50 COMBINED 0/50 1/50 3/50
May Have Been Related
  • Bone: OSTEOSARCOMA 0/50 1/50 2/50
  • Subcutaneous Tissue: FIBROMA 0/50 5/50 4/50; FIBROSARCOMA 1/50 2/50 1/50
Non-Neoplastic Lesions
  • KIDNEY: NEPHROPATHY, CHRONIC 50/50 48/50 48/50
  • TESTES: DEGENERATION 0/50 0/50 36/50
Female Rats: No Evidence
Male Mice: No Evidence
Type Organ/Tissue (Lesion)
Non-Neoplastic Lesions
  • TESTES: GERMINAL EPITHELIUM, DEGENERATION 0/49 3/49 23/50
Female Mice: Clear Evidence
Type Organ/Tissue (Lesion)
Neoplastic Lesions
  • Ovary: TUBULAR CELL ADENOMA 0/50 0/50 5/50; BENIGN MIXED TUMORS 0/50 0/50 4/50; GRANULOSA CELL TUMOR 0/50 3/50 2/50
Non-Neoplastic Lesions
  • OVARY: ATROPHY 0/50 48/50 49/50
  • ADRENAL GLAND: SPINDLE CELL, HYPERPLASIA 3/50 41/50 45/50